OnKure Therapeutics, Inc. (OKUR)
3.56
-0.07
(-1.93%)
USD |
NASDAQ |
Sep 01, 16:00
3.56
0.00 (0.00%)
After-Hours: 20:00
OnKure Therapeutics Cash from Operations (Annual) : -51.83M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -51.83M |
| December 31, 2024 | -51.12M |
| December 31, 2023 | -34.55M |
| December 31, 2022 | -47.36M |
| Date | Value |
|---|---|
| December 31, 2021 | -37.98M |
| December 31, 2020 | -18.54M |
| December 31, 2019 | -12.51M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 127.04M |
| Theriva Biologics, Inc. | -16.67M |
| Nkarta, Inc. | -88.70M |
| Unicycive Therapeutics, Inc. | -31.32M |
| ACADIA Pharmaceuticals, Inc. | 109.84M |